نتائج البحث

Temporal Characterization of Extracellular Vesicles During Cellular Therapy Using CAR-T Cells and During the Occurrence of Immune Effector Cell-Associated Neurotoxicity Syndrome (VESICANS)

• Source: Temporal Characterization of Extracellular Vesicles During Cellular Therapy Using CAR-T Cells and During the Occurrence of Immune Effector

تفاصيل العنوان

Management of chimeric antigen receptor T-cell-related toxicity of a patient affected by cytokine release syndrome and immune effector cell-associated neurotoxicity syndrome, followed by an intestinal perforation: a case report

• Authors : G. Menardi; A. Castellino; C. Castellino

Subjects: Male; Mantle cell lymphoma; Receptors, Chimeric Antigen

• Source: J Med Case RepJournal of Medical Case Reports, Vol 19, Iss 1, Pp 1-7 (2025)

تفاصيل العنوان

Immune effector cell-associated hematotoxicity: EHA/EBMT consensus grading and best practice recommendations

• Authors : Rejeski, K; Subklewe, M; Aljurf, M

• Source: BLOOD. 142(10):865-877

تفاصيل العنوان

Severe Cytokine Release Syndrome and Immune Effector Cell-associated Neurotoxicity Syndrome in a Man Receiving Immune Checkpoint Inhibitors for Lung Cancer

• Authors : Tanaka, Takaaki; Taoka, Masataka; Makimoto, Go

Subjects: nivolumab; Male; Lung Neoplasms

• Source: Intern Med

تفاصيل العنوان

Fractional order modeling of prostate cancer with pulsed treatment and the impact of effector cell killing and cell competition.

• Authors : Saber, Hicham¹ (AUTHOR); Albala, Hussien² (AUTHOR); Aljaaidi, Tariq³ (AUTHOR)

• Source: Scientific Reports. 4/16/2025, Vol. 15 Issue 1, p1-14. 14p.

تفاصيل العنوان

Study to Evaluate the Role of Siltuximab in Treatment of Cytokine Release Syndrome (CRS) and Immune Effector Cell Associated Neurotoxicity (ICANS) Related to CAR-T Cell Therapy

• Authors : Mayur Narkhede, Assistant Professor

• Source: A Phase II Pilot Study to Evaluate the Role of Siltuximab in Treatment of Cytokine Release Syndrome (CRS) and Immune Effector Cell

تفاصيل العنوان

The CXCL16/CXCR6 axis is linked to immune effector cell-associated neurotoxicity in chimeric antigen receptor (CAR) T cell therapy.

• Authors : Lu, I-Na^1,2 (AUTHOR); Müller-Miny, Louisa¹ (AUTHOR); Krekeler, Carolin³ (AUTHOR)

• Source: Genome Medicine. 6/30/2025, Vol. 17 Issue 1, p1-14. 14p.

تفاصيل العنوان

Immune Effector Cell-Associated Neurotoxicity Syndrome After CAR T-Cell Therapy and Other Psychiatric Manifestations: A Review and Case Series.

• Authors : Buciuc, Adela Georgiana¹ (AUTHOR) ; Tran, Sabrina² (AUTHOR); Weber, Mary^1,2 (AUTHOR)

• Source: Journal of Clinical Medicine. Mar2025, Vol. 14 Issue 5, p1451. 12p.

تفاصيل العنوان

A Randomized Controlled, Open, Single-center Clinical Study Evaluating the Efficacy and Safety of Umbilical Cord Blood Mononuclear Cells in Patients with Refractory Immune Effector Cell-related Hemocytopenia

• Authors : Kai Hu, Principal Investigator

• Source: A Randomized Controlled, Open, Single-center Clinical Study Evaluating the Efficacy and Safety of Umbilical Cord Blood Mononuclear Cells in Patients with Refractory Immune

تفاصيل العنوان

Severe malaria enforces short-lived effector cell differentiation but does not prevent effective secondary responses by memory CD8 T cells.

• Authors : Hildebrand, Jacob A.^1,2 (AUTHOR); Daniels, Noah R.^1,2 (AUTHOR); Dehm, Emma M.^1,2 (AUTHOR)

• Source: PLoS Pathogens. 3/31/2025, Vol. 21 Issue 3, p1-28. 28p.

تفاصيل العنوان